Drugs / Vaccine (autologous dendritic cells)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02332889 | Apr 2015 → Jul 2016 | glioma, medulloblastoma, primitive neuroectodermal tumor | University of Louisville | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vaccine (autologous dendritic cells) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02332889 ↗ |
| Modality | Vaccine | “a cancer vaccine” NCT02332889 ↗ |